Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation
- 1 March 1994
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 47 (5) , 781-788
- https://doi.org/10.1016/0006-2952(94)90477-4
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymesBiochemical Pharmacology, 1993
- Protective effect of adenosine and a novel xanthine derivative propentofylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampusBrain Research, 1990
- The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re‐uptake siteBritish Journal of Pharmacology, 1989
- The effects of torbafylline on blood flow, pO2 and function of rat ischaemic skeletal muscleEuropean Journal of Pharmacology, 1989
- Caffeine and theophylline analogues: Correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitorsLife Sciences, 1988
- PentoxifyllineDrugs, 1987
- A New Generation of Phosphodiesterase Inhibitors: Multiple Molecular Forms of Phosphodiesterase and the Potential for Drug SelectivityJournal of Medicinal Chemistry, 1985
- Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patientsAmerican Heart Journal, 1982
- Inhibition of separated forms of cyclic nucleotide phosphodiesterase from pig coronary arteries by 1,3-disubstituted and 1,3,8-trisubstituted xanthinesJournal of Medicinal Chemistry, 1981
- Selective inhibition of cyclic nucleotide phosphodiesterases by analogs of 1-methyl-3-isobutylxanthineBiochemistry, 1977